Page last updated: 2024-09-03

4-(3-chloroanilino)quinazoline and Metabolic Syndrome

4-(3-chloroanilino)quinazoline has been researched along with Metabolic Syndrome in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Barbosa, J; Baugh, SD; Coulter, E; Desai, U; Gay, JP; Gopinathan, S; Han, Q; Hari, R; Kimball, SD; Lombardo, VK; Nguyen, HV; Ni, CY; Pabba, PK; Powell, DR; Smith, A; Terranova, KM; Wilson, A; Yu, XC1

Other Studies

1 other study(ies) available for 4-(3-chloroanilino)quinazoline and Metabolic Syndrome

ArticleYear
Design, synthesis, and in vivo activity of novel inhibitors of delta-5 desaturase for the treatment of metabolic syndrome.
    Bioorganic & medicinal chemistry letters, 2015, Sep-15, Volume: 25, Issue:18

    Topics: Amides; Animals; Delta-5 Fatty Acid Desaturase; Dose-Response Relationship, Drug; Drug Design; Enzyme Inhibitors; Fatty Acid Desaturases; Humans; Liver; Metabolic Syndrome; Mice; Molecular Structure; Structure-Activity Relationship

2015